isoflurophate has been researched along with Hepatolenticular Degeneration in 1 studies
Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.
Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Reilly, S | 1 |
| Pollycove, M | 1 |
| Bank, WJ | 1 |
1 other study available for isoflurophate and Hepatolenticular Degeneration
| Article | Year |
|---|---|
Iron metabolism in Wilson's disease. Kinetic studies with iron.
Topics: Adolescent; Adult; Child; Deficiency Diseases; Erythropoiesis; Female; Hepatolenticular Degeneration | 1968 |